{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:16:40Z","timestamp":1789024600033,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-002-232-MY3"],"award-info":[{"award-number":["NSTC 112-2314-B-002-232-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["114-N0054"],"award-info":[{"award-number":["114-N0054"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jfma.2025.12.003","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:33:20Z","timestamp":1764995600000},"page":"1250-1257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors for incident or persistent SARC-F-defined sarcopenia in patients with end-stage kidney disease: a cohort study"],"prefix":"10.1016","volume":"125","author":[{"given":"Szu-Ying","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6545-6517","authenticated-orcid":false,"given":"Kyung Dong","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2892-7986","authenticated-orcid":false,"given":"Chia-Ter","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2025.12.003_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jfma.2025.12.003_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2025.12.003_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126270","article-title":"Uremic toxins and frailty in patients with chronic kidney disease: a molecular insight","volume":"22","author":"Chao","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jfma.2025.12.003_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-021-00898-1","article-title":"Sarcopenia in chronic kidney disease: a scoping review of prevalence, risk factors, association with outcomes, and treatment","volume":"110","author":"Chatzipetrou","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jfma.2025.12.003_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: european consensus on definition and diagnosis: report of the european working group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.jfma.2025.12.003_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jfma.2025.12.003_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jcsm.13425","article-title":"Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta-analysis","volume":"15","author":"Duarte","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jfma.2025.12.003_bib8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11914-022-00751-w","article-title":"Skeletal muscle complications in chronic kidney disease","volume":"20","author":"Troutman","year":"2022","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jfma.2025.12.003_bib9","first-page":"1474","article-title":"Extracellular MicroRNAs as potential biomarkers for frail kidney phenotype: progresses and precautions","volume":"15","author":"Chao","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.jfma.2025.12.003_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.jrn.2024.03.002","article-title":"Change over time in pre-end-stage renal disease 24-Hour urine creatinine as muscle mass surrogate and post-end-stage renal disease mortality","volume":"34","author":"Amin","year":"2024","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.jfma.2025.12.003_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/nu16101498","article-title":"Low-protein diet in elderly patients with chronic kidney disease stage 4 and 5 in conservative management: Focus on Sarcopenia development","volume":"16","author":"Martino","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.jfma.2025.12.003_bib12","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/jcsm.12791","article-title":"Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review","volume":"12","author":"Noor","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jfma.2025.12.003_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.799544","article-title":"Frailty as an independent risk factor for depression in patients with end-stage renal disease: a cross-sectional study","volume":"9","author":"Chi","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.jfma.2025.12.003_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jamda.2013.05.018","article-title":"SARC-F: a simple questionnaire to rapidly diagnose sarcopenia","volume":"14","author":"Malmstrom","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jfma.2025.12.003_bib15","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.14336\/AD.2019.0216","article-title":"Frailty predicts an increased risk of end-stage renal disease with risk competition by mortality among 165,461 diabetic kidney disease patients","volume":"10","author":"Chao","year":"2019","journal-title":"Aging Dis"},{"key":"10.1016\/j.jfma.2025.12.003_bib16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40620-024-01900-3","article-title":"FRAIL scale as a screening tool and a predictor of mortality in non-dialysis dependent patients","volume":"37","author":"Rodrigues","year":"2024","journal-title":"J Nephrol"},{"key":"10.1016\/j.jfma.2025.12.003_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41514-024-00173-1","article-title":"The impact of blood pressure lowering agents on the risk of worsening frailty among patients with diabetes mellitus: a cohort study","volume":"10","author":"Wang","year":"2024","journal-title":"NPJ Aging"},{"key":"10.1016\/j.jfma.2025.12.003_bib18","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.14336\/AD.2023.0225","article-title":"The impact of glucose-lowering strategy on the risk of increasing frailty severity among 49,519 patients with diabetes mellitus: a longitudinal cohort study","volume":"14","author":"Chi","year":"2023","journal-title":"Aging Dis"},{"key":"10.1016\/j.jfma.2025.12.003_bib19","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/jcsm.13078","article-title":"Simplified discriminant parameters for sarcopenia among patients undergoing haemodialysis","volume":"13","author":"Kakita","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jfma.2025.12.003_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1188971","article-title":"Validity of the SARC-F questionnaire in assessing sarcopenia in patients with chronic kidney disease: a cross-sectional study","volume":"10","author":"Du","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.jfma.2025.12.003_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clnu.2013.04.002","article-title":"Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease","volume":"33","author":"Kim","year":"2014","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.jfma.2025.12.003_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nut.2018.12.005","article-title":"Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy","volume":"62","author":"Lai","year":"2019","journal-title":"Nutrition"},{"key":"10.1016\/j.jfma.2025.12.003_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130740","article-title":"Relationship between stage of chronic kidney disease and sarcopenia in Korean aged 40 years and older using the korea national health and Nutrition examination surveys (KNHANES IV-2, 3, and V-1, 2), 2008-2011","volume":"10","author":"Moon","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2025.12.003_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jcsm.12130","article-title":"Sarcopenia among patients receiving hemodialysis: weighing the evidence","volume":"8","author":"Kittiskulnam","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jfma.2025.12.003_bib25","first-page":"371","article-title":"Sarcopenia and sarcopenic obesity in chronic kidney disease: update on prevalence, outcomes, risk factors and nutrition treatment","volume":"25","author":"Barreto Silva","year":"2022","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jfma.2025.12.003_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12891-025-08317-4","article-title":"Clinical and novel insights into risk factors for sarcopenia in dialysis patients: a systematic review and meta-analysis","volume":"26","author":"Zhang","year":"2025","journal-title":"BMC Muscoskelet Disord"},{"key":"10.1016\/j.jfma.2025.12.003_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s40520-024-02911-7","article-title":"Prediction models for sarcopenia risk in dialysis patients: a systematic review and critical appraisal","volume":"37","author":"Hou","year":"2025","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jfma.2025.12.003_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/j.jrn.2024.05.009","article-title":"Risk prediction models for sarcopenia in dialysis patients: a systematic review","volume":"35","author":"Leng","year":"2025","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.jfma.2025.12.003_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1415398","article-title":"The prevalence of sarcopenia and risk factors in the older adult in China: a systematic review and meta-analysis","volume":"12","author":"Meng","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.jfma.2025.12.003_bib30","article-title":"Epidemiology of sarcopenia: prevalence, risk factors, and consequences","volume":"144","author":"Yuan","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.jfma.2025.12.003_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1053\/j.ajkd.2013.10.013","article-title":"Risk of stroke in long-term dialysis patients compared with the general population","volume":"63","author":"Wang","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2025.12.003_bib32","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/jcsm.13275","article-title":"Association between sarcopenia and frailty in elderly patients with chronic kidney disease","volume":"14","author":"Wang","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jfma.2025.12.003_bib33","article-title":"Low muscle mass in patients receiving hemodialysis: correlations with vascular calcification and vascular access failure","volume":"10","author":"Kim","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jfma.2025.12.003_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017308","article-title":"Vascular calcification as an underrecognized risk factor for frailty in 1783 community-dwelling elderly individuals","volume":"9","author":"Lee","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jfma.2025.12.003_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034641","article-title":"Risk of major bleeding, stroke\/systemic embolism, and death associated with different oral anticoagulants in patients with atrial fibrillation and severe chronic kidney disease","volume":"13","author":"Xu","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jfma.2025.12.003_bib36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/j.ajkd.2005.09.002","article-title":"Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients","volume":"46","author":"Unruh","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2025.12.003_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3904\/kjim.2022.338","article-title":"Sarcopenia in chronic kidney disease: from bench to bedside","volume":"38","author":"Kim","year":"2023","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jfma.2025.12.003_bib38","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s12603-021-1682-7","article-title":"25OH vitamin D is no associated with muscle function loss in adults and elderly patients undergoing hemodialysis","volume":"25","author":"Marini","year":"2021","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jfma.2025.12.003_bib39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1186\/s12877-024-05506-z","article-title":"Gait abnormalities and longitudinal fall risk in older patients with end-stage kidney disease and sarcopenia","volume":"24","author":"Sun","year":"2024","journal-title":"BMC Geriatr"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625006473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625006473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:50:24Z","timestamp":1788983424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625006473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0929664625006473"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.12.003","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for incident or persistent SARC-F-defined sarcopenia in patients with end-stage kidney disease: a cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}